Costs and quality of life in patients with moderate to severe plaque‐type psoriasis in Germany: A multi‐center study

Abstract

Patients who cannot (or can no longer) be adequately managed with standard treatments are characterized by high disease activity, high costs and reduced QoL. Improved treatment options particularly for these patients are medically necessary and appear economically sensible.